DemethylisoencecalinCAS# 24672-84-2 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
| Cas No. | 24672-84-2 | SDF | Download SDF |
| PubChem ID | N/A | Appearance | Powder |
| Formula | C13H14O3 | M.Wt | 218.3 |
| Type of Compound | Phenols | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Demethylisoencecalin Dilution Calculator
Demethylisoencecalin Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 4.5809 mL | 22.9043 mL | 45.8085 mL | 91.617 mL | 114.5213 mL |
| 5 mM | 0.9162 mL | 4.5809 mL | 9.1617 mL | 18.3234 mL | 22.9043 mL |
| 10 mM | 0.4581 mL | 2.2904 mL | 4.5809 mL | 9.1617 mL | 11.4521 mL |
| 50 mM | 0.0916 mL | 0.4581 mL | 0.9162 mL | 1.8323 mL | 2.2904 mL |
| 100 mM | 0.0458 mL | 0.229 mL | 0.4581 mL | 0.9162 mL | 1.1452 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 3'-Hydroxyxanthyletin
Catalog No.:BCN0243
CAS No.:165900-08-3
- Natsudaidain
Catalog No.:BCN0242
CAS No.:35154-55-3
- Norswertianolin
Catalog No.:BCN0241
CAS No.:54954-12-0
- 5'-UMP disodium salt
Catalog No.:BCN0240
CAS No.:3387-36-8
- Licraside
Catalog No.:BCN0239
CAS No.:29913-71-1
- Thalifendine
Catalog No.:BCN0238
CAS No.:18207-71-1
- (2R,3S)-3,7,4'-Trihydroxy-5-methoxy-8-prenylflavanone
Catalog No.:BCN0237
CAS No.:1966944-04-6
- 16,25-Diacetate cyclosiversioside F
Catalog No.:BCN0236
CAS No.:452919-90-3
- Fissistigine A
Catalog No.:BCN0235
CAS No.:70420-58-5
- Echinocystic acid 28-O-beta-D-glucoside
Catalog No.:BCN0234
CAS No.:99633-30-4
- 1-Methylhydantoin
Catalog No.:BCN0233
CAS No.:616-04-6
- 2-Naphthalenecarboxylic acid, 4-(D-glucopyranosyloxy)-1-hydroxy-3-(3-hydroxy-3-methylbutyl)-, methyl ester
Catalog No.:BCN0232
CAS No.:125906-48-1
- O-Desmethyl galanthamine
Catalog No.:BCN0245
CAS No.:60755-80-8
- Anhydrobyankangelicin
Catalog No.:BCN0246
CAS No.:35214-81-4
- Galanthamine 10-Oxide
Catalog No.:BCN0247
CAS No.:134332-50-6
- O-Acetylgalanthamine
Catalog No.:BCN0248
CAS No.:25650-83-3
- Dioscoreside C
Catalog No.:BCN0249
CAS No.:344912-80-7
- Dioscoreside E
Catalog No.:BCN0250
CAS No.:435321-73-6
- 4'-O-Methyllucenin II (Diosmetin 6,8-di-C-glucoside)
Catalog No.:BCN0251
CAS No.:98813-28-6
- Gynosaponin TN2
Catalog No.:BCN0252
CAS No.:77658-95-8
- Peiioside B
Catalog No.:BCN0253
CAS No.:1610618-91-1
- Euphorbia factor L25
Catalog No.:BCN0254
CAS No.:303174-98-3
- Fuzitine
Catalog No.:BCN0255
CAS No.:142287-96-5
- Secotubeimoside I
Catalog No.:BCN0256
CAS No.:106235-32-9
Anti-Hyperglycemic Activity of Major Compounds from Calea ternifolia.[Pubmed:28216594]
Molecules. 2017 Feb 14;22(2). pii: molecules22020289.
Demethylisoencecalin (1) and caleins A (4) and C (5) (3.16-31.6 mg/kg, p.o.), the major components from an infusion of Calea ternifolia controlled postprandial glucose levels during an oral sucrose tolerance test (OSTT, 3 g/kg) in normal and nicotinamide/streptozotocin (NA/STZ, 40/100 mg/kg) hyperglicemic mice. The effects were comparable to those of acarbose (5 mg/kg). During the isolation of 1, 4, and 5, four additional metabolites not previously reported for the plant, were obtained, namely 6-acetyl-5-hydroxy-2-methyl-2-hydroxymethyl-2H-chromene (3), herniarin (6), scoparone (7), and 4',7-dimethylapigenin (8). In addition, the structure of calein C (5) was confirmed by X-ray analysis. Pharmacological evaluation of the essential oil of the species (31.6-316.2 mg/kg, p.o.) provoked also an important decrement of blood glucose levels during an OSTT. Gas chromatography coupled with mass spectrometry (GC-MS) analysis of the headspace solid phase microextraction (HS-SPME)-adsorbed compounds and active essential oil obtained by hydrodistillation revealed that chromene 1 was the major component (19.92%); sesquiterpenes represented the highest percentage of the essential oil content (55.67%) and included curcumene (7.10%), spathulenol (12.95%) and caryophyllene oxide (13.0%). A suitable High Performance Liquid Chromatography (HPLC) method for quantifying chromenes 1 and 6-hydroxyacetyl-5-hydroxy-2,2-dimethyl-2H-chromene (2) was developed and validated according to standard protocols.
